Teva Pharmaceutical Stock Analysis

TEVA
 Stock
  

USD 8.07  0.25  3.20%   

The modest gains experienced by current holders of Teva Pharmaceutical created some momentum for investors as it was traded today as low as 7.85 and as high as 8.24 per share. The company directors and management have been quite successful in maneuvering the stock at opportune times to take advantage of all market conditions in September. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.39. This high volatility is attributed to the latest market swings and not-so-good earnings reports for some of the Teva Pharmaceutical partners.
Additionally, take a look at World Market Map.
  
The Teva Pharmaceutical stock analysis report makes it easy to digest most publicly released information about Teva Pharmaceutical and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Teva Pharmaceutical Stock analysis module also helps to analyze the Teva Pharmaceutical price relationship with some important fundamental indicators such as market cap and management efficiency.

Teva Pharmaceutical Stock Analysis Notes

About 46.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.85. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Teva Pharmaceutical has Price/Earnings To Growth (PEG) ratio of 0.86. The entity recorded a loss per share of 3.63. The firm last dividend was issued on the 27th of November 2017. Teva Pharmaceutical had 2:1 split on the 1st of July 2004. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel. Teva Pharmaceutical is traded on New York Stock Exchange in the United States. To find out more about Teva Pharmaceutical Industries contact Carlo Notaristefani at 972 3 914 8213 or learn more at https://www.tevapharm.com.

Teva Pharmaceutical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Teva Pharmaceutical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Teva Pharmaceutical Industries or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Teva Pharmaceutical has very high historical volatility over the last 90 days
The company reported the previous year's revenue of 15.43 B. Net Loss for the year was (1.05 B) with profit before overhead, payroll, taxes, and interest of 7.59 B.
Latest headline from www.fool.com: Why Teva Stock Shot More Than 3 percent Higher Today - The Motley Fool

Teva Pharmaceutical Upcoming and Recent Events

Earnings reports are used by Teva Pharmaceutical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Teva Pharmaceutical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report8th of May 2017
Next Financial Report3rd of August 2017
Next Fiscal Quarter End31st of March 2017
Next Fiscal Year End12th of February 2018
Last Quarter Report31st of December 2016
Last Financial Announcement31st of March 2016

Teva Pharmaceutical Thematic Classifications

In addition to having Teva Pharmaceutical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Israel Wall Street
Large Israel companies traded on major USA exchanges

Teva Pharmaceutical Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Teva Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Teva Pharmaceutical Industries backward and forwards among themselves. Teva Pharmaceutical's institutional investor refers to the entity that pools money to purchase Teva Pharmaceutical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Capital Research Global InvestorsCommon Shares93.2 M700.6 M
Blackrock IncCommon Shares43.1 M323.9 M
Abrams Capital Management LpCommon Shares24 M180.8 M
Menora Mivtachim Holdings LtdCommon Shares23.3 M175.3 M
Migdal Insurance Financial Holdings LtdCommon Shares19.5 M146.9 M
Phoenix Holdings LtdCommon Shares18.5 M139.4 M
Clal Insurance Enterprises Holdings LtdCommon Shares19 M138.3 M
Citigroup IncPut Options8.3 M62.6 M
Citigroup IncCall Options7.9 M59.4 M
Note, although Teva Pharmaceutical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Teva Pharmaceutical Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 8.54 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Teva Pharmaceutical's market, we take the total number of its shares issued and multiply it by Teva Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Teva Pharmaceutical Profitablity

Teva Pharmaceutical's profitability indicators refer to fundamental financial ratios that showcase Teva Pharmaceutical's ability to generate income relative to its revenue or operating costs. If, let's say, Teva Pharmaceutical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Teva Pharmaceutical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Teva Pharmaceutical's profitability requires more research than a typical breakdown of Teva Pharmaceutical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (6.83) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 27.49 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.27.

Management Efficiency

The entity has return on total asset (ROA) of 3.83 % which means that it generated profit of $3.83 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of (10.03) %, meaning that it created substantial loss on money invested by shareholders. Teva Pharmaceutical management efficiency ratios could be used to measure how well teva pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 1st of October, Teva Pharmaceutical has the Risk Adjusted Performance of 0.0358, coefficient of variation of 4011.95, and Semi Deviation of 2.73. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Teva Pharmaceutical, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Teva Pharmaceutical Industries, which can be compared to its competition. Please validate Teva Pharmaceutical information ratio, and the relationship between the downside deviation and value at risk to decide if Teva Pharmaceutical is priced more or less accurately, providing market reflects its prevalent price of 8.07 per share. Given that Teva Pharmaceutical has jensen alpha of 0.2915, we advise you to double-check Teva Pharmaceutical Industries's current market performance to make sure the company can sustain itself at a future point.

Teva Pharmaceutical Price Movement Analysis

Study
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Instantaneous Trendline is a moving-average-like indicator which is formed by removing the Dominant Cycle from Teva Pharmaceutical price series.
.

Teva Pharmaceutical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Teva Pharmaceutical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Teva Pharmaceutical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Teva Pharmaceutical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Eliyahu Kalif over a month ago via Macroaxis 
Sale by Eliyahu Kalif of 55500 shares of Teva Pharmaceutical
Eli Shani over a month ago via Macroaxis 
Exercise or conversion by Eli Shani of 1581 shares of Teva Pharmaceutical subject to Rule 16b-3
Hughes Eric A over a month ago via Macroaxis 
Acquisition by Hughes Eric A of 210970 shares of Teva Pharmaceutical subject to Rule 16b-3
Ronit SatchiFainaro over three months ago via Macroaxis 
Exercise or conversion by Ronit SatchiFainaro of 14479 shares of Teva Pharmaceutical subject to Rule 16b-3
Hafrun Fridriksdottir over three months ago via Macroaxis 
Sale by Hafrun Fridriksdottir of 130000 shares of Teva Pharmaceutical
Mark Sabag over six months ago via Macroaxis 
Exercise or conversion by Mark Sabag of 20598 shares of Teva Pharmaceutical subject to Rule 16b-3
Eliyahu Kalif over six months ago via Macroaxis 
Exercise or conversion by Eliyahu Kalif of 18430 shares of Teva Pharmaceutical subject to Rule 16b-3
Amir Weiss over six months ago via Macroaxis 
Teva Pharmaceutical exotic insider transaction detected
Tal Zaks over six months ago via Macroaxis 
Acquisition by Tal Zaks of 12205 shares of Teva Pharmaceutical subject to Rule 16b-3
Andrew Weil over six months ago via Macroaxis 
Acquisition by Andrew Weil of 29673 shares of Teva Pharmaceutical subject to Rule 16b-3
Schultz Kare over six months ago via Macroaxis 
Exercise or conversion by Schultz Kare of 180000 shares of Teva Pharmaceutical subject to Rule 16b-3
Gerald Lieberman over six months ago via Macroaxis 
Acquisition by Gerald Lieberman of 14479 shares of Teva Pharmaceutical subject to Rule 16b-3

Teva Pharmaceutical Predictive Daily Indicators

Teva Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Teva Pharmaceutical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Teva Pharmaceutical Forecast Models

Teva Pharmaceutical time-series forecasting models is one of many Teva Pharmaceutical's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Teva Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Teva Pharmaceutical Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Teva Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Teva Pharmaceutical shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Teva Pharmaceutical. By using and applying Teva Pharmaceutical Stock analysis, traders can create a robust methodology for identifying Teva Pharmaceutical entry and exit points for their positions.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel. Teva Pharmaceutical is traded on New York Stock Exchange in the United States.

Current Teva Pharmaceutical Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Teva Pharmaceutical analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Teva Pharmaceutical analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
45.54Hold13Odds
Teva Pharmaceutical Industries current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Teva Pharmaceutical analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Teva Pharmaceutical stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Teva Pharmaceutical, talking to its executives and customers, or listening to Teva Pharmaceutical conference calls.
Teva Pharmaceutical Analyst Advice Details

Teva Pharmaceutical Stock Analysis Indicators

Teva Pharmaceutical Industries stock analysis indicators help investors evaluate how Teva Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Teva Pharmaceutical shares will generate the highest return on investment. By understating and applying Teva Pharmaceutical stock analysis, traders can identify Teva Pharmaceutical position entry and exit signals to maximize returns.
Quick Ratio0.59
Fifty Two Week Low6.78
Revenue Growth-3.20%
Average Daily Volume Last 10 Day9.18M
Shares Short Prior Month19.38M
Average Daily Volume In Three Month13.48M
Shares Percent Shares Out1.60%
Gross Margins47.80%
Forward Price Earnings2.82
Float Shares1.1B
Fifty Two Week High11.34
Fifty Day Average9.23
Enterprise Value To Ebitda7.45
Two Hundred Day Average8.62
Enterprise Value To Revenue2.05
Additionally, take a look at World Market Map. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for analysis

When running Teva Pharmaceutical price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Is Teva Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharmaceutical. If investors know Teva Pharmaceutical will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teva Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Teva Pharmaceutical is measured differently than its book value, which is the value of Teva Pharmaceutical that is recorded on the company's balance sheet. Investors also form their own opinion of Teva Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Teva Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teva Pharmaceutical's market value can be influenced by many factors that don't directly affect Teva Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teva Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Teva Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.